Table 1.

Antibacterial evaluation of the new vancomycin aglycone hexapeptide derivatives.

Bacteria	In Vitro MIC in μg/mL
	TEI	VAN	6	7	8	11	12	13
B. subtilis ATCC 6633	0.5	0.5	32	32	32	32	256	256
S. aureus MSSA ATCC 29213	0.5	0.5	128	256	256	256	256	256
S. aureus MRSA ATCC 33591	0.5	0.5	128	256	256	256	256	256
S. epidermidis ATCC 35984	4	2	32	32	32	256	128	128
S. epidermidis mecA	16	4	32	32	64	256	256	128
E. faecalis ATCC 29212	1	1	32	32	32	128	128	64
E. faecalis 15,376 VanA	256	256	128	256	256	256	256	256
E. faecalis ATCC 51,299 VanB	0.5	128	128	256	128	256	256	128

TEI: teicoplanin, VAN: vancomycin.